Immorta Bio
Immortabio is a biotechnology company developing AI-enabled personalized therapeutics to treat diseases of aging.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓About Immorta Bio
Immorta Bio is a company based in Miami Beach, United States. Recent Funding lists it under Health and bio. Its latest known round is a Seed round (October 2026); no sourced amount is on record for it yet. Its team on record includes Boris Reznik (CEO), Armin Rath (Chief Business Officer), Thomas Ichim (President and Chief Scientific Officer) and 1 other.
Funding rounds
- Seed · amount undisclosedSource: sec.gov
- Website created
Team
BR
Boris Reznik CEOAR
Armin Rath Chief Business OfficerTI
Thomas Ichim President and Chief Scientific OfficerVB
Vlad Bykoriz Chief Medical Officer
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
CCureBay$10.55M Series B+ · Oct 2026
Questions and sources
Immorta Bio: questions and answers
- Who works at Immorta Bio?
- Team members on record: Boris Reznik (CEO), Armin Rath (Chief Business Officer), Thomas Ichim (President and Chief Scientific Officer) and Vlad Bykoriz (Chief Medical Officer).
- Where is Immorta Bio based?
- Immorta Bio is based in Miami Beach, United States.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/immorta-bio (get a free API key).